Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
HELP
HELP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest HELP ETF News Today | Earnings, Events & Price Alerts
HELP News
Helus Pharma Advances Mental Health Drug Development
4d ago
Newsfilter
Helus Pharma Advances Psychedelic Drug Clinical Trials
4d ago
PRnewswire
Helus Pharma's Psychedelic Drug Achieves Phase 3 Success
5d ago
PRnewswire
Helus Pharma Achieves Breakthrough in Depression Treatment
5d ago
Newsfilter
Mental Health Treatment Market Set for Accelerated Growth
Feb 24 2026
PRnewswire
Mental Health Drug Market Set for Accelerated Growth
Feb 24 2026
Newsfilter
"Compass Pathways Secures Trial Victory and Rapid Funding with Magic Mushrooms and Cash"
Feb 20 2026
Marketbeat
Helus Pharma Reports Positive SPL026 Trial Results
Feb 17 2026
stocktwits
Helus Pharma's SPL026 Phase 2a Trial Data Published in Nature Medicine
Feb 17 2026
seekingalpha
Helus Pharma's SPL026 Phase 2a Trial Achieves Success
Feb 17 2026
Newsfilter
Cybin Q3 Earnings Miss Expectations
Feb 13 2026
seekingalpha
Helus Pharma Reports Q3 2025 Financial Results and Pipeline Updates
Feb 13 2026
Newsfilter
Helus Pharma Appoints New CEO to Drive Growth
Feb 10 2026
NASDAQ.COM
Next-Gen CNS Assets Attract Investor Interest
Feb 10 2026
PRnewswire
Next-Gen CNS Assets Attract Investor Interest
Feb 10 2026
Newsfilter
Helus Pharma Appoints New CEO to Drive Growth
Feb 10 2026
seekingalpha
Show More News
